RAYMEDICA TEN YEAR PDN PROSTHETIC DISC NUCLEUS CLINICAL RESULTS PRESENTED

Results from a 10 year clinical study of patients implanted with the first generation prosthetic disc nucleus (PDN) technology indicate the patients improved or maintained their range of motion and experienced early and sustained pain reduction. Sponsored by Raymedica, the details of the retrospective analysis and the findings were presented at the 6th Annual Spine Arthroplasty Society (SAS) meeting in Montreal, QC, Canada.
dBusinessNews